EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access

Adipose Tissue Dysfunction in Polycystic Ovary Syndrome

Fernando Bril, Uche Ezeh, Mina Amiri, Sana Hatoum, Lauren Pace, Yen-Hao Chen, Fred Bertrand, Barbara Gower, Ricardo Azziz iD

The Journal of Clinical Endocrinology & Metabolism · 21.12.2023 · 109 (1) · 10-24

DOI: 10.1210/clinem/dgad356 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 17.06.2023. Verfasst von Fernando Bril und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham (UAB), Birmingham, AL 35233, USA. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Insulin Resistance. Die Arbeit wurde bisher 129-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NICHD NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Polycystic ovary syndrome (PCOS) is a complex genetic trait and the most common endocrine disorder of women, clinically evident in 5% to 15% of reproductive-aged women globally, with associated cardiometabolic dysfunction. Adipose tissue (AT) dysfunction appears to play an important role in the pathophysiology of PCOS even in patients who do not have excess adiposity.

Methods

We undertook a systematic review concerning AT dysfunction in PCOS, and prioritized studies that assessed AT function directly. We also explored therapies that targeted AT dysfunction for the treatment of PCOS.

Results

Various mechanisms of AT dysfunction in PCOS were identified including dysregulation in storage capacity, hypoxia, and hyperplasia; impaired adipogenesis; impaired insulin signaling and glucose transport; dysregulated lipolysis and nonesterified free fatty acids (NEFAs) kinetics; adipokine and cytokine dysregulation and subacute inflammation; epigenetic dysregulation; and mitochondrial dysfunction and endoplasmic reticulum and oxidative stress. Decreased glucose transporter-4 expression and content in adipocytes, leading to decreased insulin-mediated glucose transport in AT, was a consistent abnormality despite no alterations in insulin binding or in IRS/PI3K/Akt signaling. Adiponectin secretion in response to cytokines/chemokines is affected in PCOS compared to controls. Interestingly, epigenetic modulation via DNA methylation and microRNA regulation appears to be important mechanisms underlying AT dysfunction in PCOS.

Conclusion

AT dysfunction, more than AT distribution and excess adiposity, contributes to the metabolic and inflammation abnormalities of PCOS. Nonetheless, many studies provided contradictory, unclear, or limited data, highlighting the urgent need for additional research in this important field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeInsulin ResistanceHumansFemaleAdultPhosphatidylinositol 3-KinasesAdipose TissueInsulinCytokinesObesityInflammationGlucose

Stichwörter der Autor:innen

DNA methylationGLP-1R agonistsGLUT-4PCOSadipokinesadiponectinadipose tissuecytokinesdietexercisefathyperandrogenisminflammationinsulin signalingmetabolic dysfunction

Substanzen

Phosphatidylinositol 3-KinasesInsulinCytokinesGlucose

Autor:innen und Institutionen

  • Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham (UAB), Birmingham, AL 35233, USA.
  • California IVF Fertility Center, Sacramento, CA 95833, USA.
  • Department of Obstetrics & Gynecology, Heersink School of Medicine, UAB, Birmingham, AL 35233, USA.
  • Reproductive Endocrinology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran 1516745811, Iran.
  • Foundation for Research and Education Excellence, Vestavia, AL 35243, USA.
  • Department of Research, Biomere-West, Richmond, CA 94806, USA.

ORCID-Profile: Ricardo Azziz

Förderung

  • NIDDK NIH HHS
  • NICHD NIH HHS
  • NIH HHS
  • National Institutes of Health
  • Helping Hand of Los Angeles, Inc
  • Research and Education Excellence

Zitieren

APA

Bril, F., Ezeh, U., Amiri, M., Hatoum, S., Pace, L., Chen, Y. H., Bertrand, F., Gower, B., & Azziz, R. (2023). Adipose Tissue Dysfunction in Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism, 109(1), 10-24. https://doi.org/10.1210/clinem/dgad356

Vancouver

Bril F, Ezeh U, Amiri M, Hatoum S, Pace L, Chen YH, et al. Adipose Tissue Dysfunction in Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism. 2023;109(1):10-24. doi:10.1210/clinem/dgad356

BibTeX
@article{Bril2023,
  author = {Bril, Fernando and Ezeh, Uche and Amiri, Mina and Hatoum, Sana and Pace, Lauren and Chen, Yen-Hao and Bertrand, Fred and Gower, Barbara and Azziz, Ricardo},
  title = {Adipose Tissue Dysfunction in Polycystic Ovary Syndrome},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2023},
  volume = {109},
  number = {1},
  pages = {10--24},
  doi = {10.1210/clinem/dgad356}
}
Kostenlos starten →